HKEX将在2025年11月28日推出生物技术期货,跟踪30家香港上市公司,头六个月免征税。 HKEX to launch biotech futures on Nov 28, 2025, tracking 30 Hong Kong-listed firms, with first-six-month levy waiver.

香港交易所与清算公司(HKEX)将于2025年11月28日推出《杭生生物技术指数未来》(Hang Seng Biotech Index Futures), Hong Kong Exchanges and Clearing (HKEX) will launch Hang Seng Biotech Index Futures on November 28, 2025, offering investors a new tool to gain exposure to Hong Kong-listed biotech, pharmaceutical, and medical devices companies eligible for southbound Stock Connect. 未来追踪30家大公司,目的是支持风险管理和快速增长部门的投资。 The futures, tracking 30 major firms, aim to support risk management and investment in a fast-growing sector. HKEX说,这次发射加强了香港作为亚洲主要衍生品中心的地位。 HKEX says the launch strengthens Hong Kong’s position as a leading Asia-based derivatives hub. 证券和期货委员会的交易税在头六个月将免收,保证利率将在以后公布。 The Securities and Futures Commission’s transaction levy will be waived for the first six months, with margin rates to be announced later. 该产品将按滚动时间表进行贸易,包括定点月份和今后三个日历月和季度。 The product will trade on a rolling schedule including the spot month and next three calendar months and quarters.